242 related articles for article (PubMed ID: 8436258)
1. Stiffening of connective tissue in elderly diabetic patients: relevance to diabetic nephropathy and oxidative stress.
Aoki Y; Yazaki K; Shirotori K; Yanagisawa Y; Oguchi H; Kiyosawa K; Furuta S
Diabetologia; 1993 Jan; 36(1):79-83. PubMed ID: 8436258
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
Aso Y; Inukai T; Tayama K; Takemura Y
Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
[TBL] [Abstract][Full Text] [Related]
7. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
8. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
Romero P; Salvat M; Fernández J; Baget M; Martinez I
J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria.
Fruehwald-Schultes B; Kern W; Beyer J; Forst T; Pfützner A; Peters A
Metabolism; 1999 Oct; 48(10):1290-3. PubMed ID: 10535393
[TBL] [Abstract][Full Text] [Related]
11. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
[TBL] [Abstract][Full Text] [Related]
12. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of oxidative stress and severity of diabetic retinopathy.
Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
[TBL] [Abstract][Full Text] [Related]
14. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
[TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of advanced glycation end-products and diabetic complications.
Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
Diabetes Res Clin Pract; 1998 Aug; 41(2):131-7. PubMed ID: 9789719
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
[TBL] [Abstract][Full Text] [Related]
17. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
Asakawa H; Tokunaga K; Kawakami F
J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
[TBL] [Abstract][Full Text] [Related]
19. Raised serum apolipoprotein (a) in active diabetic retinopathy.
Maioli M; Tonolo G; Pacifico A; Ciccarese M; Brizzi P; Kohner EM; Porta M
Diabetologia; 1993 Jan; 36(1):88-90. PubMed ID: 8436260
[TBL] [Abstract][Full Text] [Related]
20. Increases in serum lipids during pregnancy in type 1 diabetic women with nephropathy.
Biesenbach G; Janko O; Stöger H; Zazgornik J
Diabet Med; 1994 Apr; 11(3):262-7. PubMed ID: 8033524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
